BRIEF published on 03/10/2025 at 15:34, 1 year 6 months ago Goldman Sachs reduces its stake in EUROAPI Euronext Paris Participation Goldman Sachs Threshold Crossing EUROAPI
BRIEF published on 02/14/2025 at 12:20, 1 year 7 months ago Goldman Sachs Crosses Threshold in EUROAPI Acquisition Goldman Sachs Crossing Thresholds Shares And Voting Rights EUROAPI
BRIEF published on 02/11/2025 at 14:00, 1 year 7 months ago Goldman Sachs reduces its stake in EUROAPI Stock Market Goldman Sachs Threshold Crossing Transfer Of Shares EUROAPI
BRIEF published on 01/31/2025 at 14:28, 1 year 7 months ago Threshold Crossings by The Goldman Sachs Group, Inc. at EUROAPI Actions Financial Market Goldman Sachs Crossing Thresholds EUROAPI
BRIEF published on 12/09/2024 at 20:22, 1 year 9 months ago EUROAPI Enters a New Chapter with Leadership Changes Pharmaceuticals 2024 Outlook Leadership Change EUROAPI FOCUS-27 Plan
PRESS RELEASE published on 12/09/2024 at 20:17, 1 year 9 months ago EUROAPI moves into a new chapter with new Governance and Leadership EUROAPI enters a new chapter with new Governance and Leadership as Emmanuel Blin becomes Independent Chair of the Board and David Seignolle appointed Chief Executive Officer, maintaining full-year 2024 guidance Governance Leadership EUROAPI Emmanuel Blin David Seignolle
BRIEF published on 10/16/2024 at 07:05, 1 year 11 months ago Appointment of Olivier Falut as Financial Director of EUROAPI Appointment Financial Director EUROAPI Olivier Falut FOCUS-27 Transformation
PRESS RELEASE published on 10/16/2024 at 07:00, 1 year 11 months ago Olivier Falut appointed EUROAPI’s Chief Financial Officer Olivier Falut appointed EUROAPI's Chief Financial Officer. He brings 30 years of financial management experience in the industrial sector. EUROAPI focuses on innovative active ingredient solutions for global health Chief Financial Officer Industrial Sector EUROAPI Active Ingredient Solutions Olivier Falut
BRIEF published on 10/10/2024 at 20:43, 1 year 11 months ago EUROAPI secures financing for its FOCUS-27 plan Funding Sanofi EUROAPI Hybrid Bond FOCUS-27 Plan
PRESS RELEASE published on 10/10/2024 at 20:38, 1 year 11 months ago EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution EUROAPI completes financing of FOCUS-27 plan, refinancing €451M Credit Facility & issuing €200M Hybrid Bond, enhancing collaboration with Sanofi Financing Partnership Sanofi EUROAPI FOCUS-27
Published on 09/16/2026 at 23:45, 4 hours 37 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 6 hours 52 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 11 hours 27 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 13 hours 22 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 14 hours 22 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 23:45, 4 hours 37 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 5 hours 48 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 7 hours 7 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 7 hours 54 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 19:05, 9 hours 17 minutes ago EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026
Published on 09/16/2026 at 17:45, 10 hours 37 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 21 hours 22 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 10 hours ago Report on the Combined General Meeting of the 10th of September 2026
